Breast Cancer Research

official impact factor 5.79
Search for
Advanced search
Breast Cancer Research
Tools
Commentary

Clinical trial update: National Cancer Institute of Canada

Kathy Pritchard1* and Tim Whelan2

Author Affiliations

1 Toronto Sunnybrook Regional Cancer Centre

2 Juravinski Regional Cancer Centre

For all author emails, please log on.

Breast Cancer Res 2005, 7:48-51 doi:10.1186/bcr979

Published: 12 January 2005

Abstract

The Breast Cancer Site Group (BCSG) of the National Cancer Institute of Canada (NCIC) Clinical Trials Group (CTG) has conducted a wide variety of clinical trials focussing on large phase III trials of adjuvant chemotherapy, adjuvant hormonal therapy, and optimal delivery of adjuvant radiation therapy. The Group has also fostered, together with the NCIC CTG Investigational New Drug (IND) Program, a series of phase II and phase I/II studies which will be carried through if possible, into the phase III setting.